We are only able to display limited information for this firm. We display more complete information for all of the following firms:

The competition group at DLA Piper covers the full range of services, including merger control, FDI clearance, regulatory investigations, and decision appeals. The practice is particularly strong in the pharmaceutical and sports sectors, often advising major pharmaceutical companies and high-profile sports clubs and associations. Practice head Sarah Smith continues to lead on complex and high-profile merger control matters. She is supported by the ‘commercially savvy’ Matt Evans, who is regularly engaged by multinational and UK businesses on complex UK and EU competition law matters and NSIA notifications.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Matt Evans has a real and unique talent in understanding and advising the companies' needs and situations. Very business oriented, well-balanced advice. Innovative and very reactive. Good relationship with the relevant authorities. He is a key partner.'

  • ‘Matt Evans is an excellent, versatile, user-friendly and commercially savvy competition partner. He has a wealth of experience, is equally at home advising on merger control as on competition law investigations and compliance issues.'

Abbreviated data is displayed for this firm.

Key clients

  • Admiral Taverns
  • Audi
Abbreviated data is displayed for this firm.

Work highlights

  • Advised Dechra Pharmaceuticals plc on its £4.5 billion public takeover by EQT and the Abu Dhabi Investment Authority.
  • Acting for WarnerBros Discovery and Liberty Global on the sale of their jointly-owned production house All3Media to Redbird IMI for GBP 1.5bn.
Abbreviated data is displayed for this firm.